Dyspnea, Lung Cancer
Conditions
Keywords
concurrent chemotherapy, concurrent radiation
Brief summary
This is a single arm clinical trial to establish the feasibility of conducting a clinical trial of acupuncture in reducing dyspnea among lung cancer survivors who have completed chemoradiotherapy. Twelve subjects with dyspnea will be recruited to this clinical trial. Up to 10 sessions of acupuncture will be delivered over the course of 8-10 weeks. The primary outcome will be dyspnea as measured by the English version of the Cancer Dyspnea Scale at the completion of the intervention.
Interventions
PROCEDUREAcupuncture
Sponsors
Abramson Cancer Center at Penn Medicine
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of Lung Cancer (Non small cell and small cell both eligible) * Completion of concurrent CRT at least 6 months prior to randomization. * Dyspnea which worsened after Chemoradiotherapy, leading to a ATS dyspnea score greater than or equal to 2 (Walks slower than people of the same age on the level because of breathlessness or has to stop for breath when walking at own pace on level) * Ability to understand written English -Willingness to adhere to all study-related procedures * Age 18 years old * ECOG Performance Status 1-3
Exclusion criteria
* Current receipt of therapy for treatment related pneumonitis for 3 weeks. * Surgical resection of this LC (lobectomy or pneumonectomy) * Another organic cause of dyspnea necessitating treatment (eg pleural effusion appropriate for thoracentesis, rapidly progressive intrathoracic recurrence, symptomatic pulmonary embolus after CRT, untreated anemia with hemoglobin8 g/dL) * Current bleeding disorder by history * Life expectancy of 12 weeks, as assessed by primary oncologist
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dyspnea | 10 weeks |
Countries
United States
Outcome results
None listed